WhatsApp Logo Follow Now
Advertisement

Mis-Selling in Life Insurance Is Rising: 5 Red Flags to Watch Before Signing Any Policy

Advertisement
Mis-Selling in Life Insurance Is Rising: 5 Red Flags to Watch Before Signing Any Policy
Mis-Selling in Life Insurance Is Rising: 5 Red Flags to Watch Before Signing Any Policy | DailyFinancial.in
Insurance Watch  |  March 2026

Mis-Selling in Life Insurance Is Rising: 5 Red Flags to Watch Before Signing Any Policy

IRDAI’s FY25 annual report flags mis-selling as an “alarming” problem. Over 26,667 unfair-practice complaints were filed last year alone. Here’s what every Indian policyholder must know before putting pen to paper.

By D. Kush, MBA | Banking & Insurance Analyst | 15 Years in Financial Services | Updated: March 2026
IRDAI Alert (FY2024-25): Mis-selling-related grievances under Unfair Business Practices jumped 14% year-on-year, now comprising 22.14% of all life insurance complaints. An IRDAI senior official publicly stated the situation is at an “alarming level.”
26,667
Mis-selling complaints FY25
14%
Year-on-year rise in UFBP cases
22.14%
Share of total life complaints
51%
5-year policy persistency rate
49%
Private life premium via banks
Table of Contents

Why Mis-Selling Is a Crisis You Cannot Ignore

Walk into any bank branch to open an FD, and there’s a reasonable chance a relationship manager will slide a life insurance brochure across the desk before you leave. It might be framed as a “guaranteed return scheme,” a “tax-free investment,” or a “pension with life cover.” Rarely will they lead with the word “insurance.” This is the heart of the mis-selling epidemic gripping India’s life insurance sector.

The numbers are striking. IRDAI’s Annual Report 2024-25 shows that while total life insurance complaints have remained largely stable at approximately 1,20,429, the proportion classified as Unfair Business Practices (UBP) — the regulatory category that covers mis-selling — has climbed sharply, from 19.33% in FY24 to 22.14% in FY25. In absolute terms, that means 26,667 formal complaints about how policies were sold, explained, and serviced.

IRDAI Member Satyajit Tripathy left no room for ambiguity at the CII Financial Summit in Mumbai: “Grouse in life insurance is about mis-selling a product and I must say that it is at an alarming level.” Policy-makers, not just consumer activists, have officially sounded the alarm.

“Mis-selling in the Indian insurance sector is a significant concern that involves the sale of insurance products to consumers without proper disclosure of terms, conditions, or suitability.”

— IRDAI Annual Report 2024-25

But data only tells part of the story. The real damage is personal and financial. Research cited by Insurance Samadhan found that 43.3% of all benefits paid by the top 10 life insurers relate to surrendered, withdrawn, discontinued, or lapsed policies — meaning nearly half of Indian policyholders walk away from policies before they can fulfil their purpose. A customer who surrenders a policy in year two can expect to recover as little as 30% of premiums paid, per IRDAI-defined surrender value rules.

The 61-month persistency ratio — a key metric measuring how many policies stay active for five years — sits at a dismal 51%. In a country where insurance penetration languishes at just 3.7% of GDP against the global average of 7.3%, the systemic damage of mis-selling is significant: it creates mistrust, forces premature exits, and denies millions of Indians the financial protection they thought they were paying for.

To protect yourself and your family, you need to know what mis-selling actually looks like on the ground. Below are the five most common and most dangerous red flags — drawn from IRDAI data, ombudsman case analyses, and 15 years of observing how Indian financial distribution actually works.

The 5 Red Flags of Life Insurance Mis-Selling

🚩
01
Red Flag

The Policy Is Described as an “Investment” or “Savings Plan” — Not Insurance

This is perhaps the oldest trick in the mis-selling playbook. A bancassurance executive or agent positions a Unit Linked Insurance Plan (ULIP) or endowment policy as a “tax-saving investment with life cover” rather than as a life insurance product with an investment component. The word “insurance” may never even appear in the sales pitch.

Why it matters: ULIP charges — including premium allocation charges, fund management fees, policy administration charges, and mortality charges — can collectively erode 20-40% of your first-year premium in older product structures. When pitched as a pure investment, these costs are often not disclosed upfront. The buyer, expecting FD-like returns, is blindsided when surrendering early.

According to Insurance Samadhan’s Q2 2025 Trends Report, endowment policies are the single most mis-sold category of life insurance product, with complaints up 11.2% over the same period in 2024.

Before you sign: Ask the agent to show you the product’s “Customer Information Sheet” (mandatory under IRDAI rules). If they hesitate or the document isn’t provided, that alone is a compliance violation.
🚩
02
Red Flag

Returns Are Stated as “Guaranteed” Without Showing the Benefit Illustration

One of the most persistent forms of mis-selling involves agents quoting specific return figures — “you’ll get ₹25 lakhs after 20 years” — without presenting the mandatory Benefit Illustration document that shows returns at the standardised 4% and 8% scenarios mandated by IRDAI.

Verbal promises are legally unenforceable. Yet survey data from 1 Finance across 20 banks in 15 cities found that 57% of relationship managers admitted they had been instructed to sell financial products regardless of suitability. In that pressure-driven environment, optimistic verbal projections are common tools to close sales fast.

For traditional endowment and money-back plans, the actual Internal Rate of Return (IRR) is typically in the range of 4%–5.5% — far below what equity mutual funds or even tax-free bonds have historically returned. Yet these products are routinely sold as superior alternatives to PPF or NPS.

Always demand the signed Benefit Illustration at two mandatory scenarios (4% and 8% p.a.). This document is legally required and the insurer must provide it. If returns at 4% look unattractive, reconsider the product.
🚩
03
Red Flag

You Are Rushed Through the Application — No Suitability Discussion

IRDAI’s regulations require insurers and intermediaries to conduct a suitability assessment before recommending a product — this means understanding your age, income, existing coverage, financial goals, and risk appetite. In practice, especially in bancassurance settings, this step is often skipped entirely in the race to meet monthly sales targets.

The structural problem is well-documented: corporate agents — primarily banks — accounted for nearly 53% of private life insurers’ individual new business premium in FY25, with banks alone responsible for more than 49% of such premium. This concentration makes bancassurance the single highest-risk channel for mis-selling, because bank staff face enormous cross-selling pressure and often have only basic insurance training.

If an agent fills in your form, hands you papers to sign quickly, avoids discussing the policy exclusions, or does not ask about your existing insurance coverage, these are serious procedural red flags indicating that a suitability check was never conducted.

A legitimate advisor will ask detailed questions about your financial situation before recommending a product. If the conversation jumps straight to “signing formalities,” pause and request a full product explanation first.
🚩
04
Red Flag

The Policy Is Sold as a Replacement for an Existing, Active Policy

Known in insurance regulation as “policy churning” or “twisting,” this practice involves convincing a policyholder to surrender an existing policy and replace it with a new one — primarily to generate fresh commissions for the agent. Because surrender values in the early years of a policy are heavily penalised, the policyholder invariably suffers a financial loss in the transition.

IRDAI rules explicitly prohibit inducing a policyholder to lapse, forfeit, or surrender a policy in favour of a new policy when it is not genuinely in their interest. Yet this violation is hard to detect from a regulator’s perspective unless the policyholder files a complaint — which brings us back to that 26,667 figure of formal grievances, representing only a fraction of actual incidents.

Watch for language like “your old policy is not performing,” “this new product has better features,” or “your previous policy doesn’t have this latest benefit.” These can be legitimate assessments — but they can also be commission-motivated manipulation.

If asked to surrender an existing policy, demand a written, detailed comparison showing surrender loss vs. projected benefit from the new policy. Factor in the new policy’s own lock-in period before you decide.
🚩
05
Red Flag

Critical Terms and Exclusions Are Not Disclosed — Or Actively Hidden

IRDAI’s own definition of mis-selling centres on this issue: “the sale of insurance products to consumers without proper disclosure of terms, conditions, or suitability.” Non-disclosure of critical policy terms — waiting periods, exclusions, surrender charges, premium payment duration vs. policy tenure, and the distinction between sum assured and maturity benefit — is at the root of most life insurance complaints.

Common non-disclosed clauses include: limited premium payment terms (you pay for 10 years but the policy runs for 20), auto-debit or ECS mandates that make it hard to stop premiums, lock-in periods during which surrender results in capital loss, and the absence of rider coverage (e.g., critical illness or accidental death riders are separate costs, not automatic inclusions).

In a high-pressure sales environment, agents often avoid mentioning these features because they reduce the appeal of the product. A complaint filed after the free-look period typically yields little remedy: of the mis-selling grievances disposed of in FY25, more than 15,000 were decided against policyholders, while only about 11,400 were resolved in their favour.

Use your free-look period (15 days from receiving the policy document, or 30 days if sold via distance marketing). Read the policy bond carefully — if anything differs from what was verbally promised, return the policy immediately for a full refund.

Mis-Sold Policy vs. Right Policy: Know the Difference

Not every complex financial product is necessarily wrong for you — but you should be able to clearly see what you are buying and why. Use this comparison to evaluate any policy pitch you receive.

Factor Mis-Selling Scenario Ethical Sale Scenario
Product Framing RISK Pitched as “investment” or “savings scheme” SAFE Clearly described as a life insurance product
Returns Promise RISK Specific rupee amounts promised verbally SAFE Written Benefit Illustration provided at 4% & 8%
Suitability Check RISK No questions about income, goals, or existing coverage SAFE Detailed needs analysis conducted and documented
Policy Document RISK Form pre-filled; rushed signatures; no reading time SAFE Ample time provided; all terms explained clearly
Exclusions Discussed? RISK Only benefits highlighted; exclusions glossed over SAFE All exclusions, lock-ins, and surrender values disclosed
Replacement Pitch RISK Advised to surrender active policy with no comparison SAFE Written comparison provided before any recommendation
Free-Look Period RISK Agent discourages reading; downplays return right SAFE Free-look period clearly communicated, in writing

🛠️ If You Suspect You’ve Been Mis-Sold a Policy: Step-by-Step Action

  1. Within free-look period (15–30 days): Return the policy immediately to the insurer. You are entitled to a near-full premium refund (minus proportionate risk premium and medical examination charges).
  2. Write a formal grievance: File a complaint directly with the insurer’s grievance officer. Reference IRDAI’s Integrated Grievance Management System (IGMS) / Bima Bharosa portal for tracking.
  3. Escalate to IRDAI: If unresolved within 30 days, escalate via the Bima Bharosa portal (bimabharosa.irdai.gov.in) or call the IRDAI Grievance Call Centre: 1800-4254-732 (toll-free).
  4. Approach the Insurance Ombudsman: For claims or disputes up to ₹50 lakh, the Ombudsman process is free for policyholders. Contact the office in your jurisdiction.
  5. Consumer Court (NCDRC / SCDRC): For larger mis-selling losses or if other channels fail, file under the Consumer Protection Act 2019. Courts have increasingly ruled in favour of mis-selling victims.

Why Mis-Selling Persists: The Commission Incentive Problem

Understanding why mis-selling happens makes you better equipped to recognise it. The answer, in most cases, is straightforward: commissions. Research by 1 Finance Magazine found that India’s top 15 banks collectively earned over ₹21,773 crore in commissions in FY24 from selling insurance and other third-party financial products. Relationship managers at banks are often given monthly targets for insurance premium mobilisation — and their salary increments or bonuses may depend on meeting them.

IRDAI’s own data shows that bancassurance partnerships dominate: corporate agents, including bank partners, accounted for nearly 53% of private life insurers’ individual new business premium in FY25. This structural concentration means that the channel most trusted by ordinary Indians — their own bank — is also the channel carrying the highest mis-selling risk.

Until incentive structures are reformed at a systemic level — something IRDAI’s 2024-25 annual report explicitly calls for — individual vigilance remains the only reliable line of defence for policyholders. The regulator has asked insurers to conduct root-cause analysis and implement product-suitability assessments by distribution channel, but these measures are at an early stage.

Your Pre-Signature Checklist: 10 Questions to Ask Every Insurance Agent

  • Is this a life insurance product? What is the sum assured (death benefit)?
  • Can you show me the mandatory Benefit Illustration at 4% and 8% growth rates?
  • What is the total premium I will pay over the policy term?
  • What is the surrender value if I exit in Year 2, Year 5, and Year 10?
  • What are all the charges deducted? (Mortality, fund management, allocation, admin fees)
  • What are the major exclusions and waiting periods under this policy?
  • Is the premium-paying term the same as the policy term? If not, explain the difference.
  • Has a suitability assessment been conducted and documented for me personally?
  • What is my free-look period and how do I exercise it?
  • Are the returns you’ve projected guaranteed or market-linked (non-guaranteed)?

Frequently Asked Questions

Mis-selling refers to the sale of an insurance product through incomplete disclosure, unsuitable recommendation, or misrepresentation of product features — without necessarily involving outright forgery. Fraud involves fabrication of documents, forged signatures, or deliberate criminal deception. Both are actionable, but mis-selling is far more common and is addressed primarily through IRDAI’s grievance and ombudsman channels, while fraud may involve police complaints and criminal proceedings.
Yes, but it is harder. After the free-look period (15 or 30 days), you can still file a formal grievance with the insurer citing mis-selling. If the insurer does not resolve it satisfactorily, you may escalate to IRDAI via Bima Bharosa or approach the Insurance Ombudsman. Successful complaints can result in premium refunds, policy cancellations, or partial compensation — but the burden of proof rests on you to demonstrate that the policy was misrepresented. Keeping records of agent communications (WhatsApp messages, emails, brochures) is extremely helpful.
ULIPs are not inherently bad products — in their current, post-2010 IRDAI-reformed structure, charges are much lower than they were in the early 2000s. They can be suitable for investors who want a disciplined long-term investment combined with life cover, are comfortable with market risk, and can sustain the premium for the full tenure (typically 10-20 years). The problem arises when they are sold to risk-averse customers seeking fixed returns, to elderly individuals who need term insurance instead, or when the investment component is pitched while hiding the insurance charges. The product is not the problem — inappropriate, undisclosed selling is.
Buying directly through the insurer’s own website or app (direct channel) eliminates intermediary commission pressure entirely. For term insurance, online purchase is almost always the most transparent and cost-effective route. If you need advice on complex products like ULIPs or retirement plans, a SEBI-registered investment advisor or an IRDAI-licensed fee-only insurance advisor is a safer choice than a bank relationship manager or tied agent, since fee-only advisors do not earn product commissions.
You can verify an insurance agent’s licence on the IRDAI website (irdai.gov.in) under the “Intermediaries” section. Every licensed agent must carry and display a valid licence certificate. For corporate agents (banks, brokers), the licence details must be mentioned in all marketing communications. If an agent refuses to share their licence number or cannot be found in the IRDAI registry, do not proceed with a purchase through them.
DK

D. Kush, MBA

Senior Analyst — Banking & Insurance | DailyFinancial.in

With 15 years of hands-on experience across banking, life insurance distribution, and personal finance advisory in India, D. Kush covers regulatory developments, product analysis, and consumer rights issues. His work has helped tens of thousands of Indian families make informed financial decisions. All content at DailyFinancial.in is based on primary regulatory sources, IRDAI circulars, and publicly available institutional data.

Disclaimer: This article is for informational and educational purposes only. It does not constitute financial, investment, or legal advice. Insurance suitability varies based on individual financial goals, age, income, and risk profile. Readers are advised to consult a licensed financial advisor or insurance professional before making any purchase decision. All regulatory data cited is sourced from IRDAI’s Annual Report 2024-25, IRDAI public statements, Insurance Samadhan’s Q2 2025 Trends Report, and published media coverage of the same.

© 2026 DailyFinancial.in  |  All Rights Reserved  |  Content is sourced from IRDAI, RBI & primary government data  |  Not financial advice

By DKush

With over 15 years of experience in Banking, investment banking, personal finance, or financial planning, Dkush  has a knack for breaking down complex financial concepts into actionable, easy-to-understand advice. A MBA finance and a lifelong learner, Dkush is committed to helping readers achieve financial independence through smart budgeting, investing, and wealth-building strategies, Follow Dailyfinancial.in for practical tips and a roadmap to financial success!

Leave a Reply

Your email address will not be published. Required fields are marked *